Healthcare Data Market Forecasted to Triple by 2030 Amidst Real-World Evidence Boom
The mass digitization of healthcare records has created a wealth of clinical data assets, leading to a predicted 14.6% growth [...]
Mallinckrodt Files for Second Bankruptcy; Plans $1 Billion Debt Reduction Amid Opioid Litigation
Drugmaker Mallinckrodt has filed for its second bankruptcy in the US within three years, with a restructuring plan aiming to [...]
Medicare to Negotiate Prices for 10 High-Cost Drugs Under New Democratic Reform Law
Medicare will negotiate prices for ten high-cost drugs, including major diabetes medications and blood thinners, as part of a drug [...]
Medtronic’s Inceptiv System: A New Auto-Adjusting Spinal Cord Stimulator Receives EU Approval
Medtronic has developed a spinal cord stimulator called the Inceptiv system, which alleviates discomfort caused by movements shifting the position [...]
UK Economy Showing Signs of Growth Despite Skills Shortage and Employment Challenges in the Biosciences Industry
The UK economy appears to avoid a possible recession and even shows signs of growth, according to the latest data [...]
Aetion’s SURF Tool: Advancing Feasibility Assessment of Real-World Evidence in FDA Applications
Aetion®, a leader in real-world evidence (RWE) technology and analytics, has published 'SURF,' a tool intended to assist sponsors in [...]
Cellares Secures $255M in Series C Round of Funding
Cellares, a cell therapy manufacturer based in South San Francisco, announced a $255 million series C investment round to finish [...]
Atropos Health Expands into Life Sciences Sector
Atropos Health, acclaimed for its Green Button Clinical Informatics Consult Service, is expanding into the life sciences sector. It will [...]
Microsoft and Epic Expand Partnership: Generative AI Integration in Healthcare to Alleviate Workforce Burnout and Staff Shortages
Microsoft and Epic are extending their partnership to incorporate AI technologies in the healthcare sector. This joint venture aims to [...]
Boehringer Ingelheim Files Lawsuit Against U.S. Government Over Medicare’s Drug Price Negotiation Power
Boehringer Ingelheim has filed a lawsuit against the U.S. government, arguing that Medicare's new power to negotiate drug prices is [...]
Bruker to Acquire PhenomeX for $108M
Bruker Corporation is actively acquiring PhenomeX in a cash deal valued at $108 million. PhenomeX, a product of Berkeley Lights' [...]
Advancements in Healthcare: The Influential Roles of Artificial Intelligence and Data Science
The last decade in healthcare has seen notable advancements due to artificial intelligence (AI), particularly data science. By using data-driven [...]
Strategic Planning, Partnerships, and Compliance in Conflict Zones
Here's What You Need to Know: The PwC 25th Annual Global CEO Survey showed that geopolitical conflicts significantly threaten global [...]
FDA Approves Ipsen’s Ultra-Rare Bone Disease Drug Sohonos
The Food and Drug Administration (FDA) has approved Ipsen Pharmaceuticals' Sohonos, a drug designed to treat fibrodysplasia ossificans progressiva (FOP), [...]
Japanese Government Funds Arcturus Therapeutics with $115M for mRNA Vaccine Production Expansion
San Diego's RNA biotech firm, Arcturus Therapeutics, has received a $115 million grant from the Japanese government for its manufacturing [...]
Federal Appeals Court Restricts Access to Abortion Pill Mifepristone
A federal appeals court has ruled to restrict access to the abortion pill mifepristone but has not removed it from [...]
Genentech to Pay $158,208 for Environmental Violations
Genentech has agreed to pay a $158,208 fine to the U.S. Environmental Protection Agency (EPA) over environmental violations at its [...]
Rising Biotech Stocks: Key Players to Monitor
10 Things You Need to Know: Biotech stocks continue to prosper long-term despite periodic fluctuations. In 2020, prominent biotech companies [...]
Segmed Exceeds 100 Million Imaging Studies Milestone on Its Network
Segmed, a company that focuses on simplifying access to real-world medical imaging data (RWiD), has announced its network has surpassed [...]
Biopharma Companies Plan of Attack After COVID-19 Revenue Boom
The COVID era created new mass-market drugs and vaccines requiring substantial investments. However, investors and analysts urge companies to adapt [...]
Supreme Court Halts Purdue Pharma’s Bankruptcy Plan Worth Billions
The Supreme Court has ordered a temporary halt on the proposed bankruptcy plan for Purdue Pharma, [...]
Skepticism Surrounds NIH’s Long Covid Clinical Trials
The National Institutes of Health (NIH) initiated clinical trials for long Covid – persistent symptoms following [...]
BioMarin’s Voxzogo Sales Forecast Rises Despite Supply Constraints
Voxzogo's success is posing challenges for BioMarin. Here's what you need to know: BioMarin's drug, Voxzogo, is performing better than [...]
FDA Accelerates Review of HuidaGene’s Treatment for Inherited Blindness
The US Food and Drug Administration (FDA) has granted HuidaGene Therapeutics a rare pediatric disease designation (RPDD) to accelerate the [...]
AI’s Impact and Challenges in the Medical Device and Pharmaceutical Industries
AI and technologies such as computer vision are profoundly influencing the medical device and pharmaceutical industries by bolstering safety, efficiency, [...]